LBF20203PG01

LipidBank Top (トップ)

Fatty acid (脂肪酸)

Glycerolipid (グリセロ脂質)

Sphingolipid (スフィンゴ脂質)

Journals (雑誌一覧)

How to edit (ページの書き方)

Upper classes: LB LBF

IDs and Links
LipidBank	XPR1706
LipidMaps	LMFA03010143
CAS
KEGG	{{{KEGG}}}
KNApSAcK	{{{KNApSAcK}}}
mol	LBF20203PG01

δ17-Prostaglandin E1
Structural Information
Systematic Name	9-Oxo- (11α,15S) -dihydroxy-prosta- (trans-13,cis-17) -dien-1-oic acid
Common Name	δ17-Prostaglandin E1 9-Oxo- (11α,15S) -dihydroxy-prosta- (13E,17Z) -dien-1-oic acid
Symbol
Formula	C20H32O5
Exact Mass	352.224974134
Average Mass	352.46508
SMILES	C(=CC[C@@H](O)C=C[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)CC
Physicochemical Information
Melting Point
Boiling Point
Density
Optical Rotation
Refractive Index
Solubility
Source	Delta ^{17}-PGE1 is produced by the cyclooxigenase metabolism of omega -3 arachidonic acid.
Chemical Synthesis
Metabolism
Biological Activity	Delta ^{17}-PGE1 is about half as potent as PGE1 as an inhibitor of ADP-induced aggregation of rabbbit PRP. Kobzar_G et al. In humanPRP, Delta ^{17}-PGE1 is a more potent antiplatelet agonist than PGE1.
Genetic Information
Note
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

[hide]Reported Metabolites, References
Biospecies ID Compound Name Reference Comment n.a. LBF20203PG01 See above. Kobzar_G et al. 1993